Both of these cascades of events correspond well to the suggested considering COVID-19 as a dual phase phenomenon: in the first phase of infection, ACE2 promotes viral entry, but in the later phase, it acts protectively against respiratory failure and COVID-19-related death (33). The gene discussed is ACE2; the disease is COVID-19.